Can an athlete have too much ticker? Hypertrophic cardiomyopathy in young athletes
Article first published online: 29 JUL 2012
© 2012 The Authors. Journal of Paediatrics and Child Health © 2012 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
Journal of Paediatrics and Child Health
Volume 48, Issue 10, pages E156–E160, October 2012
How to Cite
Fitzgerald, N. M., Sherwood, M. and Fitzgerald, D. A. (2012), Can an athlete have too much ticker? Hypertrophic cardiomyopathy in young athletes. Journal of Paediatrics and Child Health, 48: E156–E160. doi: 10.1111/j.1440-1754.2012.02504.x
- Issue published online: 24 OCT 2012
- Article first published online: 29 JUL 2012
- Accepted for publication 20 October 2011.
- hypertrophic cardiomyopathy;
- sudden cardiac death
Sudden cardiac death (SCD) is an uncommon but devastating potential consequence of participation in competitive sport. It is seen in adolescent and young adult athletes. The most common cause of this, hypertrophic cardiomyopathy (HCM), is a genetic disorder responsible for more than a third of cases and is manageable. Screening is undertaken for HCM, using differing strategies in Europe and North America. Screening and early diagnosis have reduced the mortality rate but has come at a significant economic cost. The evidence and relevant arguments for and against screening are presented together with management strategies as reflected by an illustrative case.